Sort
48,018 grants matching “immunotherapy”
SURGERY IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$4,704,543John Wayne Cancer Institute · P01 · FY2001 · CA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$4,695,150Martin Cheever · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · CA
Building on the success of the adoptive immunotherapy of cancer
$4,687,435Nicholas P Restifo · Basic Sciences · Z01 · FY2007 · CA
Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic efficacy of bnAb against breast milk HIV transmission
$4,686,370Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
I4C 2.0: Immunotherapy for Cure
$4,677,761Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2022 · AI
Extramural Research Facility Construction Projects. Ros*
$4,675,896Kelvin P Lee · Roswell Park Cancer Institute Corp · C06 · FY2010 · RR
I4C 2.0: Immunotherapy for Cure
$4,669,992Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2023 · AI
I4C 2.0: Immunotherapy for Cure
$4,653,643Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2025 · AI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$4,630,856Wilton B Williams · Duke University · UM1 · FY2025 · AI
Adult Leukemia Research Center
$4,628,534Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$4,614,298Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Simian Vaccine Evaluation Unit (SVEU)
$4,610,244Phillip D Markham · Advanced Bioscience Laboratories, Inc. · N01 · FY2011 · AI
OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder
$4,609,902Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2023 · DA
General Clinical Research Center
$4,604,412Arthur Garson · University Of Virginia · M01 · FY2006 · RR
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$4,601,742Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2017 · DA
OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder
$4,597,509Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2021 · DA
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2016 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2017 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2018 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,592,950David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2019 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2016 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,036Luis J. Montaner · Wistar Institute · UM1 · FY2018 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,035Luis J. Montaner · Wistar Institute · UM1 · FY2017 · AI
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
$4,589,035Luis J. Montaner · Wistar Institute · UM1 · FY2020 · AI